Cue Biopharma Inc at Jefferies Global Healthcare Conference in New York Transcript
Hello, everyone. Thanks for being here. I'm Amin Makarem, one of the biotech analysts here at Jefferies.
I'm happy to introduce and welcome Shao-Lee Lin, CEO of Cue Biopharma.
This is a standard presentation format, and with that, I'll hand it over to Shao.
Thank you so much for the introduction, Amin, and thanks, Jefferies, for the opportunity for us to present at your conference. Here are our forward-looking statements, which I'm sure you'll all study. It is an incredibly exciting time for us at Cue.
Over the past year, I've been actively drug hunting for transformational therapies alongside a small and highly experienced team. Throughout my career, both in big pharma and smaller biotech, I found that among many promising programs that one might find in a given year, only one or two actually have the potential to fundamentally change outcomes for patients.
When we began this
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

